APA
Morcillo S., Cardona F., Rojo-Martínez G., Almaraz M. C., Esteva I., Ruiz-De-Adana M. S., Olveira G., García-Fuentes E., Gómez-Zumaquero J. M. & Soriguer F. (20120424). Effect of the combination of the variants -75G/A APOA1 and Trp64Arg ADRB3 on the risk of type 2 diabetes (DM2). : Clinical endocrinology.
Chicago
Morcillo Sonsoles, Cardona Fernando, Rojo-Martínez Gemma, Almaraz M Cruz, Esteva Isabel, Ruiz-De-Adana María Soledad, Olveira Gabriel, García-Fuentes Eduardo, Gómez-Zumaquero Juan Miguel and Soriguer Federico. 20120424. Effect of the combination of the variants -75G/A APOA1 and Trp64Arg ADRB3 on the risk of type 2 diabetes (DM2). : Clinical endocrinology.
Harvard
Morcillo S., Cardona F., Rojo-Martínez G., Almaraz M. C., Esteva I., Ruiz-De-Adana M. S., Olveira G., García-Fuentes E., Gómez-Zumaquero J. M. and Soriguer F. (20120424). Effect of the combination of the variants -75G/A APOA1 and Trp64Arg ADRB3 on the risk of type 2 diabetes (DM2). : Clinical endocrinology.
MLA
Morcillo Sonsoles, Cardona Fernando, Rojo-Martínez Gemma, Almaraz M Cruz, Esteva Isabel, Ruiz-De-Adana María Soledad, Olveira Gabriel, García-Fuentes Eduardo, Gómez-Zumaquero Juan Miguel and Soriguer Federico. Effect of the combination of the variants -75G/A APOA1 and Trp64Arg ADRB3 on the risk of type 2 diabetes (DM2). : Clinical endocrinology. 20120424.